These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 24899247)

  • 21. Nephrogenic systemic fibrosis presenting as myopathy: a case report with histopathologic correlation.
    Edgar E; Woltjer R; Whitham R; Gultekin SH; Watnick S; Cupler EJ
    Neuromuscul Disord; 2010 Jun; 20(6):411-3. PubMed ID: 20462761
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Recent topics related to nephrogenic systemic fibrosis associated with gadolinium-based contrast agents.
    Kitajima K; Maeda T; Watanabe S; Ueno Y; Sugimura K
    Int J Urol; 2012 Sep; 19(9):806-11. PubMed ID: 22571387
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Osseous metaplasia late in the course of nephrogenic systemic fibrosis.
    Berk DR; Miller A; Scarlett D; Wippold FJ; Bayliss SJ; Lu D
    Dermatol Online J; 2010 Aug; 16(8):3. PubMed ID: 20804680
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Gadolinium-Naive Nephrogenic Systemic Fibrosis of Breast Mimicking Inflammatory Breast Carcinoma.
    Halteh P; Huang J; Wildman HF; Magro CM
    Am J Dermatopathol; 2017 Apr; 39(4):322-324. PubMed ID: 28323787
    [No Abstract]   [Full Text] [Related]  

  • 25. Findings of osseous sclerotic bodies: a unique sequence of cutaneous bone formation in nephrogenic systemic fibrosis.
    Kartono F; Basile A; Roshdieh B; Schwimer C; Shitabata PK
    J Cutan Pathol; 2011 Mar; 38(3):286-9. PubMed ID: 20726931
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Nephrogenic fibrosing dermopathy: report of two cases.
    Aires NB; Sotto MN; Nico MM
    Acta Derm Venereol; 2007; 87(6):521-4. PubMed ID: 17989891
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Update on nephrogenic systemic fibrosis: are we making progress?
    Haemel AK; Sadowski EA; Shafer MM; Djamali A
    Int J Dermatol; 2011 Jun; 50(6):659-66. PubMed ID: 21595657
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Nephrogenic systemic fibrosis: a review.
    Chen AY; Zirwas MJ; Heffernan MP
    J Drugs Dermatol; 2010 Jul; 9(7):829-34. PubMed ID: 20677539
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The debate between gadolinium versus erythropoietin in a renal transplant patient with nephrogenic systemic fibrosis.
    Hashemi P; Sina B; Rietkerk W; Safai B
    J Nephrol; 2013; 26(1):48-54. PubMed ID: 22573525
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Nephrogenic systemic fibrosis: in a child with primary hyperoxaluria.
    Ozkur E; Kıvanç Altunay I; Erdem Y; Özçelik G; Tuncel D
    Clin Exp Dermatol; 2019 Jan; 44(1):70-72. PubMed ID: 30198190
    [No Abstract]   [Full Text] [Related]  

  • 31. UV-A1 therapy for nephrogenic systemic fibrosis.
    Tran KT; Prather HB; Cockerell CJ; Jacobe H
    Arch Dermatol; 2009 Oct; 145(10):1170-4. PubMed ID: 19841406
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Nephrogenic systemic fibrosis and use of MR contrast media].
    Christiansen RE; Sviland L; Sekse I; Svarstad E
    Tidsskr Nor Laegeforen; 2009 Jan; 129(3):180-2. PubMed ID: 19180161
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Risk of using gadolinium in patients with renal insufficiency].
    Greloni G; Rosa Diez G; Hidalgo Parra I; Torre A; García Mónaco R; Algranati S
    Medicina (B Aires); 2008; 68(4):346-7. PubMed ID: 18786896
    [No Abstract]   [Full Text] [Related]  

  • 34. Nephrogenic systemic fibrosis: report of an additional case with granulomatous inflammation.
    Wilford C; Fine JD; Boyd AS; Sanyal S; Abraham JL; Kantrow SM
    Am J Dermatopathol; 2010 Feb; 32(1):71-5. PubMed ID: 19940755
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Quantitative assessment of dermal cellularity in nephrogenic systemic fibrosis: a diagnostic aid.
    Nazarian RM; Mandal RV; Kagan A; Kay J; Duncan LM
    J Am Acad Dermatol; 2011 Apr; 64(4):741-7. PubMed ID: 21414498
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Rapid improvement of nephrogenic systemic fibrosis with rapamycin therapy: possible role of phospho-70-ribosomal-S6 kinase.
    Swaminathan S; Arbiser JL; Hiatt KM; High W; Abul-Ezz S; Horn TD; Shah SV
    J Am Acad Dermatol; 2010 Feb; 62(2):343-5. PubMed ID: 20115955
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Nephrogenic fibrosing dermopathy/nephrogenic systemic fibrosis with diaphragmatic involvement in a patient with respiratory failure.
    Kucher C; Steere J; Elenitsas R; Siegel DL; Xu X
    J Am Acad Dermatol; 2006 Feb; 54(2 Suppl):S31-4. PubMed ID: 16427988
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Nephrogenic fibrosing dermopathy in a patient with acute renal failure never requiring dialysis.
    Cassis TB; Jackson JM; Sonnier GB; Callen JP
    Int J Dermatol; 2006 Jan; 45(1):56-9. PubMed ID: 16426379
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The evolution of osseous metaplasia in localized cutaneous nephrogenic systemic fibrosis: a case report.
    Wiedemeyer K; Kutzner H; Abraham JL; Thakral C; Carlson JA; Tran TA; Hausser I; Hartschuh W
    Am J Dermatopathol; 2009 Oct; 31(7):674-81. PubMed ID: 19633532
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Nephrogenic fibrosing dermopathy and high-dose erythropoietin therapy.
    Swaminathan S; Ahmed I; McCarthy JT; Albright RC; Pittelkow MR; Caplice NM; Griffin MD; Leung N
    Ann Intern Med; 2006 Aug; 145(3):234-5. PubMed ID: 16880475
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.